VERAgene is the latest generation of non-invasive prenatal test on our market, which was introduced for the first time by our laboratory and is the only test performed by a sample of both parents for possible genetic disorders during pregnancy.
VERAgene screens for aneuploidies, microdeletions and 2000 mutations for 100 monogenetic diseases, making it a comprehensive solution with just one test for expectant parents.
HOW IS VERAgene MADE?
In order to perform the test, a DNA sample from the father is needed by taking a buccal swab, ie a swab from the inside of the cheek and a sample of venous blood from the mother.
Together the DNA sample from the father and the blood sample from the mother are analyzed using the latest generation of technology and bioinformatics analysis.
WHY IS IT SAID THAT VERAGENE HAS SUPERIOR CHARACTERISTICS IN RELATION TO THE OTHER NON-INVASIVE PRENATAL TESTS?
Unlike other non-invasive prenatal tests, now with just one test VERAgene can do a complete screening of the baby’s health from a very early stage of pregnancy. VERAgene has superior features as it is the only test in our market that includes a sample from both parents and is the only test that offers screening for aneuploidies, microdeletions and 2000 mutations for 100 monogenetic diseases. At the same time, VERAgene, unlike other prenatal tests, has no age limit for future parents and has a competitive price.
WHEN CAN I MAKE THE TEST?
The test can be done by any pregnant woman starting from the 10th week. There are no age restrictions for future parents (mother and biological father) to take the test.
WHAT DOES THE TEST DETECT?
- Aneuploidies – Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), Patau syndrome (Trisomy 13).
- Sex chromosome aneuploidies – Turner syndrome (Monosomy X), Triple X syndrome (Trisomy X), Klinefelter syndrome (XXY), Jacobs syndrome (XYY) and XXYY syndrome.
- 100 monogenetic diseases – see the list of all diseases on the following link.
- Microdeletions – DiGeorge syndrome (22q11.2), 1p36 deletion syndrome (1p36), Smith-Magenis syndrome (17p11.2) and Wolf-Hirschhorn syndrome (4p16.3).
- Gender of the baby
WHAT IMPACT DO 100 MONOGENETIC DISEASES DETECTED BY VERAgene ON THE QUALITY OF LIFE?
Monogenetic diseases for which screening is often associated with severe conditions and with a significant impact on quality of life. They are most often manifested by symptoms such as congenital anomalies, developmental delays, hearing loss, blindness, metabolic disorders and many others.
The cumulative risk of the fetus being affected by one of the monogenetic diseases detected by VERAgene is 1 in 50 in moderate to high risk pregnancies.
ARE THERE LIMITATIONS IF IT IS ABOUT GEMINI PREGNANCY OR IVF PREGNANCY?
No. The test is validated and can be done during twin pregnancies as well as for IVF pregnancies.
IS THERE A RISK FOR THE MOTHER AND THE BABY?
No! The test does not pose any risk to the mother or baby. A sample of blood is taken from the mother as for any other routine laboratory analysis.
WHAT IS THE PRICE OF THE TEST?
The price of VERAgene is 37,900 denars.
PROMOTIONAL, during the campaign with every VERAgene made every pregnant woman receives a gift “Pregnancy diary” as well as a Gender reveal balloon.
For more detailed gift information, our VERAgene sampling team will let you know.
IS A SCHEDULED APPOINTMENT NEEDED?
The analysis can be done in all laboratories of Avicenna Laboratory without a previously scheduled appointment.
WHERE CAN I FIND OUT MORE DETAILS OF VERAgene?
For more detailed information about the test, consult your doctor or to talk to our representative, call us on 02 3179 001.